CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...
from NDTV News - Special https://ift.tt/HAad5FK
Subscribe to:
Post Comments (Atom)
"No Paper Work": What's New In SIR 2.0
The Phase 2 of the nationwide rollout of the Special Intensive Revision or SIR of voter rolls would require no paperwork. The user-friendly ...
Popular Posts
-
Tigress Arrowhead (T-84), one of Ranthambore's most celebrated big cats, passed away at the age of 14, forest officials confirmed on Thu...
-
By BY THE NEW YORK TIMES from NYT U.S. https://ift.tt/2JDppgp
-
By Unknown Author from NYT Today’s Paper https://ift.tt/2DNrMx7
Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine
CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...
from NDTV News - Special https://ift.tt/HAad5FK
from NDTV News - Special https://ift.tt/HAad5FK
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment